|
|
Volumn 23, Issue 10, 2005, Pages 2426-2428
|
|
Side effects and good effects from new chemotherapeutic agents: Case 3. Bortezomib in primary refractory plasmacytoma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBUMIN;
BORTEZOMIB;
CD79A ANTIGEN;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
FLUORODEOXYGLUCOSE F 18;
IMMUNOGLOBULIN G;
LEUKOCYTE ANTIGEN;
PARAPROTEIN;
PREDNISOLONE;
SARCOLYSIN;
TRACER;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
PYRAZINE DERIVATIVE;
ADULT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ARTICLE;
BONE DESTRUCTION;
BONE MARROW BIOPSY;
CASE REPORT;
CATHETERIZATION;
CELL INFILTRATION;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE COURSE;
FEMALE;
GRAFT VERSUS HOST REACTION;
HUMAN;
HUMAN TISSUE;
IMMUNOELECTROPHORESIS;
IMMUNOHISTOCHEMISTRY;
IMMUNOPHENOTYPING;
MEDIASTINUM MASS;
MONOCLONAL IMMUNOGLOBULINEMIA;
MULTIPLE CYCLE TREATMENT;
PLASMACYTOMA;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
TREATMENT OUTCOME;
BONE MARROW TRANSPLANTATION;
DISEASE FREE SURVIVAL;
DRUG RESISTANCE;
MEDIASTINUM TUMOR;
MIDDLE AGED;
PATHOLOGY;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW TRANSPLANTATION;
BORONIC ACIDS;
DISEASE-FREE SURVIVAL;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
MEDIASTINAL NEOPLASMS;
MIDDLE AGED;
PLASMACYTOMA;
PYRAZINES;
TREATMENT OUTCOME;
|
|
EID: 17144362510
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.04.079 Document Type: Article |
|
Times cited : (16)
|
|
References (7)
|
